Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
-
Authors :
Breznik JA; McMaster Immunology Research Center, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & controlSARS-CoV-2 variants
-
Source:
Journal of the American Medical Directors Association [J Am Med Dir Assoc] 2023 May; Vol. 24 (5), pp. 753-758. Date of Electronic Publication: 2023 Mar 28.Publisher: Elsevier Country of Publication: United States NLM ID: 100893243 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Grupel D; Internal Medicine B, Soroka University Medical Center, Beer Sheva, Israel; Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. Electronic address: .
Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans
-
Source:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Apr; Vol. 29 (4), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Wagenhäuser I; Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans
-
Source:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Apr; Vol. 29 (4), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Hashimoto Y; Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. Electronic address: .
Subjects: BNT162 Vaccine* ; COVID-19*; Male
-
Source:
Ophthalmology [Ophthalmology] 2023 Mar; Vol. 130 (3), pp. 256-264. Date of Electronic Publication: 2022 Oct 26.Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Sanada T; Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.; Honda T
Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans
-
Source:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2023 Mar; Vol. 29 (3), pp. 339-346. Date of Electronic Publication: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Kohmer N; Institute for Medical Virology, University Hospital, Goethe University Frankfurt am Main, Frankfurt, Germany. Electronic address: .; Stein S
Subjects: BNT162 Vaccine* ; COVID-19*; Humans
-
Source:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Mar; Vol. 128, pp. 166-175. DatePublisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Yang SL; Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Malaysia. Electronic address: .; Ripen AM
Subjects: BNT162 Vaccine* ; COVID-19*; Humans
-
Source:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Mar; Vol. 128, pp. 98-101. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Edelstein M; Ziv Medical Center, Safed, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. Electronic address: .
Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans
-
Source:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Oct; Vol. 135, pp. 57-62. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Risk M; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.; Miao H
Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult SARS-CoV-2 variants
-
Source:
The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2023 Jan; Vol. 72 (1), pp. 147-152. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 9102136 Publication Model: Print-Electronic Cited Medium:
Record details